With Persistent Treatment, Epigenetic Age Acceleration In Obstructive Sleep Apnea Can Be Reversed.

With Persistent Treatment, Epigenetic Age Acceleration In Obstructive Sleep Apnea Can Be Reversed.

Bysleephealth

Researchers from the Child Health Research Institute, the School of Medicine, University of Missouri, Columbia, MO, (USA), the Translational Research Unit, Instituto de Investigación Sanitaria de Aragón (Spain), and the Hospital Universitario Miguel Servet, Zaragoza, (Spain) published an article in early 2022 showing that Epigenetic age acceleration in obstructive sleep apnea is reversible with the…

Apnimed Raises $62.5 Million To Advance Its Obstructive Sleep Apnea (OSA) Medication Into Phase 3 Trials

Apnimed Raises $62.5 Million To Advance Its Obstructive Sleep Apnea (OSA) Medication Into Phase 3 Trials

Bysleephealth

Apnimed believes there is a market for a new pharmaceutical therapeutic option for OSA, which affects 25 million Americans. Muscles that normally maintain the upper airway open collapse periodically during sleep in these people, resulting in occasional low oxygen levels and long-term morbidity. Although continuous positive air pressure can be useful, many patients do not…